Dr Sophy Shih is a senior health economist with expertise in economic evaluation and health service research. She has extensive experience of designing and implementing trial-based economic assessments, performing economic evaluations, and building economic models. Dr Shih was trained in health economics, public health and biomedical science. She has worked on a broad range of topics including viral infection, rare genetic diseases, cancers, diabetes, psycho-oncology, and disability with a focus on prevention and screening. 

In 2019, Dr Shih joined the SERP at the Kirby Institute and the NPESU at the Centre for Big Data Research in Health as a Senior Research Fellow/Health Economist. Her current working programs focus on HCV and HIV testing strategies and treatment uptake and scaling up of point-of-care (POC) technology to enhance testing for HCV and HIV infection and reduce mortality and morbidity of these infectious diseases.

Dr Shih was a subcommittee member of the Clinical Guidelines Network at Cancer Council Australia and co-authored the “Economics of Keratinocyte Cancer” chapter of the NHMRC-endorsed clinical guidelines “Clinical Practice Guidelines for Keratinocyte Cancer”.